Skip to main content
Clinical Trials/NCT04073420
NCT04073420
Recruiting
Not Applicable

Medtronic Cardiac Surgery Post Market Clinical Follow-up Registry

Medtronic Cardiac Surgery51 sites in 10 countries2,700 target enrollmentDecember 2, 2019

Overview

Phase
Not Applicable
Intervention
Surgical Heart Valve Repair Products
Conditions
Valve Disease, Heart
Sponsor
Medtronic Cardiac Surgery
Enrollment
2700
Locations
51
Primary Endpoint
Identify unique failure modes
Status
Recruiting
Last Updated
19 days ago

Overview

Brief Summary

This registry is being conducted to support ongoing post-market surveillance activities.

Registry
clinicaltrials.gov
Start Date
December 2, 2019
End Date
December 31, 2039
Last Updated
19 days ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Medtronic Cardiac Surgery
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  • Patient has or is intended to receive or be treated with an eligible product
  • Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment

Exclusion Criteria

  • Patient who is, or is expected to be, inaccessible for follow-up
  • Patient prohibited from participation by local law
  • Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results

Arms & Interventions

Surgical Valve Replacement and/or Repair Patients

Intervention: Surgical Heart Valve Repair Products

Surgical Valve Replacement and/or Repair Patients

Intervention: Surgical Heart Valve Replacement Products

Outcomes

Primary Outcomes

Identify unique failure modes

Time Frame: 10 years

Identify trends in adverse device effects

Time Frame: 10 years

Study Sites (51)

Loading locations...

Similar Trials